5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Physical Dependence

NCT01549652 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

133

Enrollment

OTHER

Sponsor class

Conditions

Opioid Withdrawal
Physical Dependence

Interventions

DRUG: Ondansetron
DRUG: Placebo
DRUG: Morphine
DRUG: Naloxone 0.4 mg/70 kg
DRUG: Naloxone 0.8 mg/70 kg

Sponsor

Stanford University

Collaborators

[object Object]